The Carbon Disclosure Project recently presented their reports for 2010. It is always interesting to read and understand where the large, often multinational, companies are moving when it comes to green gas emissions. We all remember the weak results from the UN Climate Change meeting in Copenhagen in December 2009, COP15, and the conclusion made by me and many others that industry’s contributions in fighting climate change probably is more important than ever.
I have shown this slide many times here on the blog. It can be summarized by using the words of our head of manufacturing in Pfizer, Nat Ricciardi:
”Pfizer exceeded its initial goal to reduce greenhouse gas emissions by achieving a 43 percent reduction relative to revenue between 2000 and 2007. The company’s second goal, to be achieved between 2007 and the end of 2012, is to cut greenhouse gases by 20 percent on an absolute basis. We’ve made significant progress on our current goal. Energy teams at Pfizer facilities around the world completed more than 500 conservation-related projects in 2009, greatly reducing Pfizer’s annual energy usage while cutting C02 emissions by 120,000 metric tons.”
The quote has been taken from the press release where Pfizer comments on the Carbon Disclosure Project Reports for 2010.
So what do the reports tell us?
Companies identify significant opportunities from their efforts on fighting climate change. And to learn more about these opportunities it is of course wise to engage with the Carbon Disclosure Leaders. And I am proud to tell that Pfizer was ranked as number 1 in the health care sector when looking on S&P 500-companies. If we however look on the Global 500-companies we have three peers ahead of us. It is still a good result, but shows that we can be even better by benchmarking towards those three: Bayer, Novo Nordisk, and GlaxoSmithKline (GSK). I would like to say a special congratulations to our colleagues in Bayer who achieved one of the over-all top results (a carbon disclosure score of 95).
Learn more about Pfizer’s work on Climate Change via this link, and more about Bayer’s efforts via this link. Information on Novo Nordisk’s progarms are found here, and GSK’s programs are described here.